[7] Zhong X , He H , Zhang C , et al. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression[J]. Journal of Affective Disorders, 2016, 201:124-...
美国医药巨头强生(JNJ)近日公布了抗抑郁新药esketamine 2个III期临床研究的数据,尽管结果并不像许多人所希望看到的那么强烈,但仍传递出了一些令人鼓舞的信号,靶向NMDA受体的其他药物开发商也可能从这一结果中得到安慰,毕竟强生的数据为NMDA受体调制机制...
At Greenbrook, we specialize in TMS therapy and Spravato for depression. Antidepressants and talk therapy aren't your only option. We can be your next step.
At Greenbrook, we specialize in TMS therapy and Spravato for depression. Antidepressants and talk therapy aren't your only option. We can be your next step.
At Greenbrook, we specialize in TMS therapy and Spravato for depression. Antidepressants and talk therapy aren't your only option. We can be your next step.
At Greenbrook, we specialize in TMS therapy and Spravato for depression. Antidepressants and talk therapy aren't your only option. We can be your next step.
At Greenbrook, we specialize in TMS therapy and Spravato for depression. Antidepressants and talk therapy aren't your only option. We can be your next step.
spectrum of problems to help clients and their families. After an in depth consultation, our clinicians will determine whether talk therapy, medication management, TMS therapy or Spravato® (Esketamine) is the most appropriate treatment for you. We accept all major commercial insurances and ...
3D) revealed that esketamine therapy exhibited remarkable improvements in mechanical and thermal pain thresholds, decreased immobility period in forced swim and tail suspension trials, heightened central area entries and dwell time during the OFT, and significantly enhanced sucrose ingestion in SNL model ...
Currently, eight patients continue to receive esketamine infusion therapy, others underwent endometriosis surgery (n = 2), switched pain treatment (n = 1), or were non-responders (n = 6). Conclusions: Esketamine infusion therapy could be a potential and a viable option to treat chronic ...